The UK Competition Appeal Tribunal’s Misguided Reprieve for Pfizer’s Excessive Pricing Abuse

by Frederick M. Abbott

published in IIC - International Review of Intellectual Property and Competition Law

Volume 49, Number 7 (2018)

IIC (2018) 49:845-853

DOI 10.1007/s40319-018-0734-y

ISSN 0018-9855